Acurx Pharmaceuticals, Inc.
ACXP
$3.10
$0.3211.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.56M | 5.91M | 6.06M | 4.64M | 3.71M |
| Total Receivables | 48.40K | 40.20K | 40.20K | -- | 51.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 85.00K | 158.20K | 53.50K | 161.60K | 100.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.69M | 6.11M | 6.16M | 4.81M | 3.86M |
|
|
|||||
| Total Current Assets | 7.69M | 6.11M | 6.16M | 4.81M | 3.86M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.69M | 6.11M | 6.16M | 4.81M | 3.86M |
|
|
|||||
| Total Accounts Payable | 6.80K | 4.40K | 4.40K | 3.40K | 4.80K |
| Total Accrued Expenses | 2.41M | 2.46M | 2.59M | 2.49M | 3.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.42M | 2.47M | 2.59M | 2.49M | 3.24M |
|
|
|||||
| Total Current Liabilities | 2.42M | 2.47M | 2.59M | 2.49M | 3.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.42M | 2.47M | 2.59M | 2.49M | 3.24M |
|
|
|||||
| Common Stock & APIC | 80.56M | 77.35M | 75.28M | 71.78M | 67.94M |
| Retained Earnings | -75.29M | -73.71M | -71.72M | -69.47M | -67.32M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.27M | 3.64M | 3.57M | 2.31M | 615.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.27M | 3.64M | 3.57M | 2.31M | 615.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.27M | 3.64M | 3.57M | 2.31M | 615.10K |
|
|
|||||